Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 685-705
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.685
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.685
Figure 1 Schematic representation of the diabetic cardiomyopathy phases.
Each background color corresponds to its respective phase: green (early phase), yellow (advanced phase), red (late phase). The red line represents the incremental nature of symptom severity. SNS: Sympathetic nervous system; GLUT4: Glucose transporter type 4; RAAS: Renin-Angiotensin-Aldosterone System.
- Citation: Kumric M, Ticinovic Kurir T, Borovac JA, Bozic J. Role of novel biomarkers in diabetic cardiomyopathy. World J Diabetes 2021; 12(6): 685-705
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/685.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.685